Tag: Jiahe Li
-
Congratulations to BME Faculty on Promotions
Learn more about our faculty promotions, which become effective later this summer and early fall 2026.
-
Jiahe Li Receives Wu Yi-fang Junior Faculty Award
Dr. Li leads a synthetic biology lab that engineers bacteria as programmable therapeutics — including probiotics that neutralize cancer-causing gut toxins and bacteria that activate anti-tumor immune responses.
-
Collins Chimezie Receives Rackham International Fellowship
Award enables expanded focus on targeting bacterial toxins through probiotics, with the goal of reducing colorectal cancer and inflammatory bowel disease risk.
-
Jiahe Li Lab Examines Breakthrough in Engineering Probiotic Defenses Against Early-Onset Colon Cancer
Dr. Li’s team has developed an engineered probiotic designed to neutralize genotoxic threats in the gut, shifting the focus from treatment to prevention in colon cancer research.
-
Investigating the Oral Microbiome to Gain Greater Understanding of Oral Health
This research focuses on the complex interplay between oral bacteria and host tissues, paving the way for potential therapeutic strategies against oral and systemic diseases.
-
Harnessing Gut Bacteria to Combat Cancer: Innovations in Tumor-Targeted Immunotherapy
A team of researchers has examined a promising new approach, which uses engineered non-pathogenic bacteria to enhance the body’s immune response against tumors.
-
Jiahe Li to Receive 2024 Cellular and Molecular Bioengineering Young Innovator Award
The Young Innovators award is issued by Cellular and Molecular Bioengineering (CMBE), a journal focused on “research that studies how cellular behavior arises from molecular-level interactions to tackle the challenge of improving human health.”
-
Jiahe Li Receives Swim Across America–Motor City Mile Grant
Dr. Li’s research focuses on the development of molecular and live cell-based therapeutics.
-
U-M BME Assistant Professor Jiahe Li receives NIH Director’s New Innovator Award
Award supports unusually innovative research from early career investigators who are within 10 years of their final degree or clinical residency and have not yet received a research project grant or equivalent NIH grant.